Behrman RE, Kliegman RMNelson Essentials of Pediatrics. 4th ed. Philadelphia, PA: WB Saunders Company; 2002:445-446.
2.
Seeley WW, Marty FM, Holmes TM, et al. Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology. 2007;69;156-165.
3.
Mannonen L., Herrgård E., Valmari P., et al. Primary human herpesvirus-6 infection in the central nervous system can cause severe disease. Pediatric Neurology. 2007;37:186-191.
4.
Red Book.2006Report of the Committee on Infectious Diseases. American Academy of Pediatrics. 27th ed. pp. 375-377.
5.
Pöhlmann C., Schetelig J., Reuner U., et al. Cidofovir and foscarnet for treatment of human herpesvirus 6 encephalitis in a neutropenic stem cell transplant recipient. Clin Infect Dis. 2007;44:e118-e120.
6.
Hall CB, Long CE, Schnabel KC, et al. Human herpes-6 infection in children. A prospective study of complications and reactivation. N Engl J Med. 1994;331: 432-438.
7.
Ward KN, Andrews NJ, Verity CM, Miller E., Ross EMHuman herpesviruses-6 and -7 each cause significant neurologic morbidity in Britain and Ireland. Arch Dis Child. 2005;90:619-623.
8.
Birnbaum T., Padovan CS, Sporer B., et al. Severe meningoencephalitis caused by human herpesvirus 6 type B in an immunocompetent woman treated with ganciclovir. Clin Infect Dis. 2005;40:887-889.